Turn Therapeutics Inc. Common Stock (NASDAQ:TTRX) — Market Cap & Net Worth
Market Cap & Net Worth: Turn Therapeutics Inc. Common Stock (TTRX)
Turn Therapeutics Inc. Common Stock (NASDAQ:TTRX) has a market capitalization of $249.03 Million ($249.03 Million) as of August 1, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #15586 globally and #3661 in its home market, demonstrating a -11.81% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Turn Therapeutics Inc. Common Stock's stock price $8.36 by its total outstanding shares 29788040 (29.79 Million). Review Turn Therapeutics Inc. Common Stock total liabilities to assess the company's total debt and financial obligations.
Turn Therapeutics Inc. Common Stock Market Cap History: 2025 to 2026
Turn Therapeutics Inc. Common Stock's market capitalization history from 2025 to 2026. Data shows growth from $117.36 Million to $249.03 Million (0.00% CAGR).
Turn Therapeutics Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Turn Therapeutics Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of TTRX by Market Capitalization
Companies near Turn Therapeutics Inc. Common Stock in the global market cap rankings as of August 1, 2026.
Key companies related to Turn Therapeutics Inc. Common Stock by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #220 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #424 globally with a market cap of $64.60 Billion USD.
- Argen-X (BR:ARGX): Ranked #543 globally with a market cap of $49.55 Billion USD ( €42.38 Billion EUR).
- UCB SA (BR:UCB): Ranked #563 globally with a market cap of $47.34 Billion USD ( €40.49 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #220 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $477.10 |
| #424 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $64.60 Billion | $762.63 |
| #543 | Argen-X | BR:ARGX | $49.55 Billion | €745.00 |
| #563 | UCB SA | BR:UCB | $47.34 Billion | €222.90 |
Turn Therapeutics Inc. Common Stock Historical Marketcap From 2025 to 2026
Between 2025 and today, Turn Therapeutics Inc. Common Stock's market cap moved from $117.36 Million to $ 249.03 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $249.03 Million | +112.18% |
| 2025 | $117.36 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of Turn Therapeutics Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $249.03 Million USD |
| MoneyControl | $249.03 Million USD |
| MarketWatch | $249.03 Million USD |
| marketcap.company | $249.03 Million USD |
| Reuters | $249.03 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Turn Therapeutics Inc. Common Stock
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and de… Read more